Commonwealth Equity Services, LLC Novavax Inc Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Novavax Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 39,798 shares of NVAX stock, worth $337,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,798

Previous 43,437 8.38%

Holding current value

$337,089

Previous $550,000 8.55%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$10.71 - $17.11 $38,973 - $62,263	-3,639 Reduced 8.38%	39,798 $503,000
Q2 2024 Jul 31, 2024	SELL	$3.89 - $20.97 $82,397 - $444,186	-21,182 Reduced 32.78%	43,437 $550,000
Q1 2024 Apr 29, 2024	BUY	$3.76 - $6.02 $174,129 - $278,792	46,311 Added 252.95%	64,619 $309,000
Q4 2023 Feb 06, 2024	BUY	$4.8 - $7.67 $4,804 - $7,677	1,001 Added 5.78%	18,308 $88,000
Q3 2023 Oct 23, 2023	BUY	$6.81 - $9.74 $14,988 - $21,437	2,201 Added 14.57%	17,307 $125,000
Q2 2023 Aug 10, 2023	BUY	$6.67 - $9.52 $12,066 - $17,221	1,809 Added 13.6%	15,106 $112,000
Q1 2023 May 11, 2023	SELL	$5.76 - $12.48 $86 - $187	-15 Reduced 0.11%	13,297 $92,000
Q4 2022 Feb 07, 2023	BUY	$8.86 - $25.04 $15,983 - $45,172	1,804 Added 15.68%	13,312 $136,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $30,994 - $129,632	-1,703 Reduced 12.89%	11,508 $209,000
Q2 2022 Jul 19, 2022	BUY	$36.28 - $75.29 $74,374 - $154,344	2,050 Added 18.37%	13,211 $679,000
Q1 2022 May 04, 2022	SELL	$69.73 - $142.9 $111,777 - $229,068	-1,603 Reduced 12.56%	11,161 $822,000
Q4 2021 Jan 31, 2022	BUY	$134.56 - $217.97 $23,009 - $37,272	171 Added 1.36%	12,764 $1.83 Million
Q3 2021 Oct 29, 2021	BUY	$177.8 - $270.58 $488,238 - $743,012	2,746 Added 27.89%	12,593 $2.61 Million
Q2 2021 Aug 11, 2021	BUY	$121.0 - $257.67 $25,773 - $54,883	213 Added 2.21%	9,847 $2.09 Million
Q1 2021 May 04, 2021	SELL	$112.98 - $319.93 $352,158 - $997,221	-3,117 Reduced 24.45%	9,634 $1.75 Million
Q4 2020 Feb 11, 2021	SELL	$78.74 - $139.5 $212,834 - $377,068	-2,703 Reduced 17.49%	12,751 $1.42 Million
Q3 2020 Nov 05, 2020	BUY	$79.44 - $178.51 $443,036 - $995,550	5,577 Added 56.46%	15,454 $1.67 Million
Q2 2020 Aug 12, 2020	SELL	$13.86 - $83.61 $65,280 - $393,803	-4,710 Reduced 32.29%	9,877 $823,000
Q1 2020 May 11, 2020	BUY	$3.93 - $16.0 $4,857 - $19,776	1,236 Added 9.26%	14,587 $198,000
Q4 2019 Feb 05, 2020	BUY	$3.69 - $5.22 $49,265 - $69,692	13,351 New	13,351 $53,000

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Novavax Inc Transaction History